HE
Cybin Inc. Common Stock (HELP)
NASDAQ·Healthcare·Biotechnology
$4.31
+0.47%
Mkt Cap $212.05M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$22.00
Range $22.00 – $22.00
Implied Upside
+410.4%
Consensus $22.00 vs current $4.31
NASDAQ·Healthcare·Biotechnology
$4.31
+0.47%
Mkt Cap $212.05M
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$22.00
Range $22.00 – $22.00
+410.4%
Consensus $22.00 vs current $4.31